Clinical Trial Update: Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Voyager V1 in combination with cemiplimab in cancer patients, with conditions including melanoma, head and neck squamous cell c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma
• Melanoma

Drugs mentioned

• Cemiplimab (cemiplimab)
• Voyager V1

Snippet

Sponsor: Vyriad, Inc. | Conditions: Melanoma, Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING